Finally, another study measured the effect of acute administration of an SGLT1 and 2 inhibitor (O'Neill et al., 2015), which has little relevance on the impact of long term therapy with specific SGLT‐2 inhibition in animals or patients with established diabetes. Here, SLC5A1 is linked to diabetes mellitus.